Combination of Osimertinib with Concurrent Chemotherapy and Hormonal Therapy for Synchronous NSCLC, Hormone Receptor-Positive Breast Cancer, and Triple-Negative Breast Cancer: Case...

por Park, Changsu L., Moria, Feras, Saleh, Ramy R.
Publicado 2023

Concurrent dose-finding of a novel cancer drug with and without a second agent

por Wages, Nolan A., Saleh, Ramy R., Braun, Thomas M.
Publicado 2023

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec

por Hu, Jason, Aprikian, Armen G., Saleh, Ramy R., Dragomir, Alice
Publicado 2022

Influence of Competing Risks on Estimates of Recurrence Risk and Breast Cancer-specific Mortality in Analyses of the Early Breast Cancer Trialists Collaborative Group

por Saleh, Ramy R., Nadler, Michelle B., Desnoyers, Alexandra, Rodin, Danielle L., Abdel-Qadir, Husam, Amir, Eitan
Publicado 2020

Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis

por Saleh, Ramy R., Peinado, Paloma, Fuentes-Antrás, Jesús, Pérez-Segura, Pedro, Pandiella, Atanasio, Amir, Eitan, Ocaña, Alberto
Publicado 2019

Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors

por Saleh, Ramy R., Meti, Nicholas, Ribnikar, Domen, Goldvaser, Hadar, Ocana, Alberto, Templeton, Arnoud J., Seruga, Bostjan, Amir, Eitan
Publicado 2020

Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis

por Tedeschi, Anna Lisa, Eslami, Zohreh, Garoufalis, Evgenia, Saleh, Ramy R, Omeroglu, Atilla, Altinel, Gulbeyaz, Ait-Tihyaty, Maria, Jean-Claude, Bertrand, Mihalcioiu, Catalin
Publicado 2015